SNCA and Parkinson disease: By triggering NLRP3 activation in human induced pluripotent stem cells (iPSC)-derived microglia through TLR2 engagement and mitochondrial damage, α-synuclein species have been shown to directly contribute to innate immunological activation in PD [56, 57].